-
Document de presse | 2007.03.11
BCG: should clinical trials be reconducted?
The various BCG strains used to vaccinate against tuberculosis throughout the world may not all have the same level of effectiveness. This was the conclusion of a study conducted by researchers from Institut Pasteur, published today in the "Proceedings of the National Academy of Science, USA". Press release Paris, march 12, 2007 Over three billion individuals...
-
Document de presse | 2004.02.19
Institut Pasteur/ Inserm : Joint research on the Nipah virus
Two teams from the Institut Pasteur and Inserm, in co-operation with Malaysian researchers, have recently successfully tested a candidate vaccine against the Nipah Virus. This virus, still undiscovered in 1998, was responsible for the deaths of 105 people in Malaysia in 1999. It is expanding at an alarming speed in South-East Asia. Currently there is no treatment in the fight against this...
-
News | 2020.09.03
Monkeypox: the epidemic potential will continue increasing, with diminishing herd immunity against viruses responsible for smallpox
Monkeypox is an emerging infectious disease for which outbreak frequency and expected outbreak size in human populations have steadily increased. The geographic spread of monkeypox cases has expanded beyond the forests of central Africa, where cases were initially found, to other parts of the world, where cases have been imported. This transmission pattern is likely due to the worldwide decline...
-
Article | 2024.04.30
Albert Calmette, pioneering social medicine
From Nice to Lille, via Ho Chi Minh City and Phnom Penh, many schools, hospitals and streets are named after Calmette. And for good reason, as all of these were places where Albert Calmette worked to improve hygiene and healthcare. A pioneer of social medicine, his work on tuberculosis focused on both research and health education.
-
Fiche maladie | 2024.03.12
Mpox (formerly monkeypox)
Mpox is a virus that was initially present in animals, especially rodents in Africa, and now circulates among humans – it is referred to as an emerging zoonotic disease. The disease caused by this virus is also known as mpox (formerly monkeypox), and presents as a mild form of smallpox, with less severe symptoms and a lower case-fatality rate (the number of deaths as a proportion of the number of...
-
Document de presse | 2005.01.10
SouthEast Asia: Institut Pasteur Mobilizes
In response to the risk of epidemics in the regions affected by the disaster, the Institut Pasteur, which is engaged in the battle against infectious diseases on a daily basis, has mobilized. The expert in charge of the Institut Pasteur Emergency Cell for Biological intervention (CIBU) is currently on a mission in Sri Lanka to participate in evaluating the risk of epidemics in this region. At the...
-
Document de presse | 2017.09.25
Dengue: understanding the mechanisms that prevent the development of symptoms following infection
Scientists from the Institut Pasteur in Paris and the Institut Pasteur in Cambodia, in collaboration with teams from the CNRS and Inria, have demonstrated that asymptomatic dengue infection in children is associated with activation of the immune system via control mechanisms, resulting in the elimination of viral infection without excessive immune activation. This paper, published in the...
-
News | 2020.11.24
Researchers from Hong-Kong University - Pasteur Research Pole and Institut Pasteur of New Caledonia are winners of the "Pasteur Network Talent Award" 2020.
«Pasteur Network Talent Awards» 2020 were presented on Thursday 19 November 2020 to Dr Sophie Valkenburg and Dr Roman Thibeaux by Pr Pierre-Marie Girard, Institut Pasteur vice-president international Affairs and by Prof. Stewart Cole, President of The Institut Pasteur.Due to the COVID-19 pandemic, these awards were presented by videoconference during the 52nd Council of Directors of the...
-
News | 2021.05.31
Diphtheria outbreak in Yemen: an epidemiology study
Diphtheria is a severe infection caused in humans by toxigenic strains of Corynebacterium diphtheriae bacteria. If left untreated, it leads to death in 5 to 25% of cases. It generally affects the upper respiratory tracts, causing pseudomembrane formation and sometimes leading to suffocation. The infection can be complicated by systemic symptoms caused by the diphtheria toxin. Scientists from the...
-
Article | 2020.08.13
The Institut Pasteur Innovation Accelerator
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...